MiR-892b silencing activates NF-kB and promotes aggressiveness in breast cancer

Cancer Research

Volumn 76, Issue 5, 2016, Pages 1101-1111

  Jiang, Lili ^a,b   Yu, Liang ^c   Zhang, Xin ^b   Lei, Fangyong ^b   Wang, Lan ^d   Liu, Xiangxia ^c   Wu, Shu ^b   Zhu, Jinrong ^e   Wu, Geyan ^e   Cao, Lixue ^e   Liu, Aibin ^e   Song, Libing ^b   Li, Jun ^e  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 892B; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; MIRN892 MICRORNA, HUMAN; POLYUBIQUITIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN TARGETING; SURVIVAL RATE; TUMOR INVASION; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; DNA METHYLATION; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICRORNAS; NF-KAPPA B; POLYUBIQUITIN; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION;

EID: 84961690136     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-1770     Document Type: Article

References (45)

1. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46:705-16.
2. Karin M, Greten FR NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5:749-59.
3. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008; 132:344-62.
4. Hoesel B, Schmid JA The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 2013; 12:86.
5. Chen ZJ. Ubiquitination in signaling to and activation of IKK. Immunol Rev 2012; 246:95-106.
6. Adhikari A, Xu M, Chen ZJ Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 2007; 26:3214-26.
7. Chen ZJ. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 2005; 7:758-65.
8. Shen RR, Zhou AY, Kim E, O'Connell JT, Hagerstrand D, Beroukhim R, et al. TRAF2 is an NF-kappaB-activating oncogene in epithelial cancers. Oncogene 2015; 34:209-16.
9. Doppler H, Liou GY, Storz P. Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity. PLoS One 2013; 8:e53676.
10. Zheng M, Morgan-Lappe SE, Yang J., Bockbrader KM, Pamarthy D, Thomas D, et al Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2. Cancer Res 2008; 68:7570-8.
11. Cai PC, Shi L, Liu V.W., Tang HW, Liu IJ, Leung TH, et al Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-kappaB signaling. Oncotarget 2014; 5:7549-62.
12. Omori E, Matsumoto K, Zhu S., Smart RC, Ninomiya-Tsuji J. Ablation of TAK1 upregulates reactive oxygen species and selectively kills tumor cells. Cancer Res 2010; 70:8417-25.
13. Melisi D, Xia Q, Paradiso G., Ling J, Moccia T, Carbone C, et al. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. J Natl Cancer Inst 2011; 103:1190-204.
14. Jin G, Klika A, Callahan M, Faga B, Danzig J, Jiang Z, et al. Identification of a human NF-kappaB-activating protein, TAB3. Proc Natl Acad Sci USA 2004; 101:2028-33.
15. Zhao N, Wang R, Zhou L., Zhu Y, Gong J, Zhuang SM MicroRNA-26b suppresses the NF-kappaB signaling and enhances the chemo sensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. Mol Cancer 2014; 13:35.
16. Li J, Zhang N, Song L.B., Liao WT, Jiang LL, Gong LY, et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008; 14:3319-26.
17. Gong H, Song L, Lin C, Liu A, Lin X, Wu J, et al. Downregulation of miR-138 sustains NF-kappaB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Clin Cancer Res 2013; 19:1083-93.
18. Jackson-Bernitsas D.G., Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, et al. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 2007; 26:1385-97.
19. Zhang L, Blackwell K, Altaeva A., Shi Z, Habelhah H. TRAF2 phosphorylation promotes NF-kappaB-dependent gene expression and inhibits oxidative stress-induced cell death. Mol Biol Cell 2011; 22:128-40.
20. Moreno-Garcia M.E., Sommer K, Rincon-Arano H, Brault M., Ninomiya-Tsuji J, Matesic LE, et al Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-kappaB activation. Mol Cell Biol 2013; 33:1149-63.
21. ∗ promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB/IkappaBalpha negative feedback loop. J Clin Invest 2012; 122:33-47.
22. Jiang L, Wu J, Yang Y., Liu L, Song L, Li J., et al. Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer 2012; 12:406.
23. Jiang L, Song L, Wu J., Yang Y, Zhu X, Hu B., et al. Bmi-1 promotes glioma angiogenesis by activating NF-kappaB signaling. PLoS One 2013; 8:e55527.
24. Cai Z, Tchou-Wong KM, Rom WN. NF-kappaB in lung tumorigenesis. Cancers (Basel) 2011; 3:4258-68.
25. Dougan M, Li D, Neuberg D., Mihm M, Googe P, Wong K.K., et al. A dual role for the immune response in a mouse model of inflammation-associated lung cancer. J Clin Invest 2011; 121:2436-46.
26. Connelly L, Barham W, Pigg R., Saint-Jean L, Sherrill T, Cheng D.S., et al. Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection. J Cell Physiol 2010; 222:73-81.
27. Geymayer S, Doppler W. Activation of NF-kappaB p50/p65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression. FASEB J 2000; 14:1159-70.
28. Zhou Y, Eppenberger-Castori S, Eppenberger U., Benz CC. The NFkappaB pathway and endocrine-resistant breast cancer. Endocr Relat Cancer 2005; 12 Suppl 1:S37-46.
29. Shostak K, Chariot A. NF-kappaB, stem cells and breast cancer: the links get stronger. Breast Cancer Res 2011; 13:214.
30. Liu M, Sakamaki T, Casimiro M.C., Willmarth NE, Quong AA, Ju X, et al The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res 2010; 70: 10464-73.
31. Helbig G, Christopherson KW 2nd, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, et al. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 2003; 278:21631-8.
32. Biswas DK, Shi Q, Baily S., Strickland I, Ghosh S, Pardee A.B., et al. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A 2004; 101:10137-42.
33. Sovak MA, Bellas RE, Kim D.W., Zanieski GJ, Rogers AE, Traish AM, et al Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997; 100:2952-60.
34. Frasor J, Weaver AE, Pradhan M, Mehta K. Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines. Endocrinology 2008; 149: 6272-9.
35. Pradhan M, Bembinster LA, Baumgarten S.C., Frasor J. Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements. J Biol Chem 2010; 285:31100-6.
36. Park KJ K.V., O'Malley BW, Yamamoto Y, Gaynor RB Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol Cell 2005; 18:71-82.
37. Tu Z, Prajapati S, Park K.J., Kelly NJ, Yamamoto Y, Gaynor RB. IKK alpha regulates estrogen-induced cell cycle progression by modulating E2F1 expression. J Biol Chem 2006; 281:6699-706.
38. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97.
39. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-5.
40. Jiang L, Mao P, Song L., Wu J, Huang J, Lin C., et al. miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 2010; 177:29-38.
41. Lin C, Liu A, Zhu J., Zhang X, Wu G, Ren P., et al. miR-508 sustains phosphoinositide signalling and promotes aggressive phenotype of oesophageal squamous cell carcinoma. Nat Commun 2014; 5:4620.
42. Xiao ZG, Deng ZS, Zhang Y.D., Zhang Y., Huang ZC. Clinical significance of microRNA-93 downregulation in human colon cancer. Eur JGastroenterol Hepatol 2013; 25:296-301.
43. Zhao G, Wang B, Liu Y., Zhang JG, Deng SC, Qin Q, et al miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Mol Cancer Ther 2013; 12:2569-80.
44. Hu H, Li Y, Gu J., Zhu X, Dong D, Yao J., et al. Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosisinleukemic K562 cells. Leuk Lymphoma 2010; 51:694-701.
45. Ma L, Reinhardt F, Pan E., Soutschek J, Bhat B, Marcusson E.G., et al. Therapeutic silencingofmiR-10b inhibits metastasisinamouse mammary tumor model. Nat Biotechnol 2010; 28:341-7.